The American Medical Association (AMA) has been consistently outspoken against proposed legislation looking to authorize pharmacists to leverage test results to directly diagnose patients. AMA warns that such “scope creep” is detrimental to patient health because an isolated lab test depicts only a snapshot of overall health, which is not enough to determine treatment. AMA stresses that pharmacists are not trained to diagnose patients, and it has defeated pharmacist-prescribing proposals in Alabama and Louisiana. Pushing …
Read More
